(Genestra Brands) MenoRelief
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
Se questo prodotto fosse venduto in Francia
Nessun punto rilevato secondo le norme che applichiamo.
Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.
Composizione
| Ingrediente medicinale e fonte | Per unità posologica, secondo la fonte | Massimo giornaliero, adulto |
|---|---|---|
| Passiflora incarnata Fonte : Passiflora incarnata - Herb top Estratto : Matériel brut sec Rapporto di estrazione : 4-6:1 Equivalente di pianta secca : 200-300 mg | 50 mg | Non calcolata |
| Crocus sativus Fonte : Crocus sativus - Stigmate Estratto : Matériel brut sec Rapporto di estrazione : 3:1 Equivalente di pianta secca : 42 mg Potenza : 3,48 % Crocin | 14 mg | Non calcolata |
| Crocus sativus Fonte : Crocus sativus - Stigmate Potenza : 0,03 % 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde | Non precisata | Non calcolata |
Ingredienti non medicinali
Cellulose, Hypromellose, Gomme de gellane, Stéarate de magnésium, Maltodextrine
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes | minimum : 18 ans | 1 Capsule | 2 par jour |
Usi autorizzati in Canada
Passiflora incarnata is traditionally used in Herbal Medicine as a sleep aid (during times of mental stress). Passiflora incarnata is traditionally used in Herbal Medicine to help relieve restlessness and/or nervousness (nervine/calmative). Used in Herbal Medicine to help relieve restlessness and/or nervousness (calmative). Helps to support mood balance. (affron) Helps to relieve restlessness and/or nervousness (calmative). Supports positive effects on symptoms of perceived stress such as fatigue, weariness, and irritability. Helps to reduce the symptoms of perceived stress, such as fatigue, weariness, and irritability. Helps to improve restorative sleep in individuals experiencing sleeplessness. Helps improve sleep quality in individuals experiencing sleeplessness. Helps to support/maintain (healthy) mood balance. Clinically proven to support/maintain (healthy) mood balance. (affron is) Clinically shown to relieve restlessness and/or nervousness (calmative). Clinically shown to support positive effects on symptoms of perceived stress such as fatigue, weariness, and irritability. Clinically shown to reduce the symptoms of perceived stress such as fatigue, weariness, and irritability. Clinically shown to improve restorative sleep in individuals experiencing sleeplessness. Supports the management of symptoms associated with perimenopause. Helps improves sleep quality. Clinically proven to help improve sleep quality. Clinically proven to help improve sleep quality in 4 weeks. Clinically proven to improve sleep quality in individuals experiencing sleeplessness. May help to support healthy mood balance during perimenopause. Helps to support healthy mood balance during perimenopause. Clinically shown to help relieve symptoms associated with perimenopause. Helps to support mood balance after awakening. Helps to support healthy mood balance after awakening. Nighttime sleep aid. Helps to reduce symptoms of menopause such as facial flushing, night sweats, sleep disturbances and nervousness. Clinically shown to help relieve symptoms of menopause such as facial flushing, night sweats, sleep disturbances and nervousness. Helps promote/maintain/support sexual health in menopausal women. Clinically shown to help promote/maintain/support sexual health in menopausal women. Helps support healthy mood balance during menopause. Helps support emotional aspects of sexual health in women. Helps to reduce cortisol levels, a biomarker of physical stress. Helps to reduce cortisol levels in the blood, a leading indicator of stress. Clinically shown to help reduce menopausal symptoms including hot flashes, night sweats, low energy, difficulty sleeping, difficulty concentrating, irritability/nervousness, muscle and joints discomfort, headaches, paresthesia (tingling, burning sensation of the skin), vertigo and vaginal dryness. MS-10 helps to provide menopausal symptom relief.
Testo originale in inglese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Cautions and Warnings : Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen. If you suffer from any psychological disorder and/or condition such as frequent anxiety or depression, consult a healthcare practitioner prior to use. Sleep aid: Consult a healthcare practitioner/healthcare provider/healthcare professional/doctor/physician if sleeplessness persists continuously for more than 4 weeks (chronic insomnia). Consult a healthcare practitioner prior to use if you are taking antidepressants. Avoid taking with alcohol or products that cause drowsiness.
Testo originale in inglese.
Scheda del prodotto
- Altri nomi
- (Genestra Brands) Meno Daily, (Genestra Brands) MenoPlus, (Genestra Brands) MenoPro
- Titolare
- Nestle Canada Inc. dba (Atrium Innovations/Genestra Brands/Pure Encapsulations/Garden of Life Canada/Trophic Canada/SISU/Wobenzym/Bountiful Canada Vitamins/Nature's Bounty/Vital Proteins Canada)
- NPN o DIN-HM
- 80129321
- Stato
- Licenza attiva
- Data della licenza
- 1 febbraio 2024
- Data di revisione
- 10 aprile 2026
- Forma
- Capsule
- Via di somministrazione
- Orale
- Tipo di domanda
- Générale (non traditionelle)
Fonte
Scheda ufficiale Health Canada, licenza 80129321
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
Avvertenze ufficiali (Health Canada)
Health Canada pubblica avvertenze su questi ingredienti:
- Passiflora incarnata
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
PASSIONFLOWER -PASSIFLORA INCARNATA
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: Sleep aid.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Berardi et al. 2002: DiPiro et al. 2002).
Fonti citate da Health Canada (2)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiological Approach, 5th edition. New York (NY): McGraw-Hill Co. Inc.; 2002
Condizione di applicazione: Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condizione di applicazione: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).
Fonti citate da Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
When using this product avoid taking with alcohol or products that cause drowsiness (EMA 2014; Brinker 2010).
Fonti citate da Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).
Fonti citate da Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
Reazioni avverse note
Stop use if hypersensitivity/allergy occurs (EMA 2014).
Fonti citate da Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.
Elenco nella revisione ufficiale del (registro: Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze).
Il prodotto è cambiato? Fotografi la confezione.
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.